RNA-based therapies are gaining importance for their ability to target diseases at the genetic level. Over fifteen RNA-based therapies have gained regulatory approval, with numerous additional candidates progressing through the clinical pipeline.

Here are the key RNA modalities and our corresponding services:
✔ siRNA - Silences disease-causing genes through RNA interference
Our custom siRNA with >95% purity and knockdown efficiency comparable to knockout, supporting long-term RNAi.

✔ miRNA - Regulates gene expression for various diseases
Our High-specificity miRNA synthesis with >95% purity and low off-target rates, ensuring precise gene regulation.

✔ ASOs - Targets specific RNA sequences to inhibit harmful proteins
Our Custom ASOs with up to 98% purity, <0.01% batch variation, and 200+ modification options.

✔ mRNA Vaccines - Enables rapid development and strong immune responses
Our one-stop IVT mRNA production with >95% purity, up to 10 kb length, and ±5% length precision.

✔ sgRNA - Guides in gene editing applications
Our high-performance sgRNA with AI-powered design, >70% cleavage efficiency, and highly reproducible gene editing.

These innovations highlight the expanding potential of RNA therapeutics. We would be happy to discuss how our services can support your research and development needs.
 
 
Contact Us

 
Looking for more? These services might be just what you need:
RNA Synthesis Gene Editing DNA Synthesis
 
 
Synbio Technologies LinkedIn X Facebook Facebook

Thank you for connecting with us! Click "Subscribe" to receive valuable insights and news. If you prefer not to receive further emails, just hit "Unsubscribe" — your choice is always respected.
Synbio Technologies LLC
9 Deer Prk Dr., Suite J-25, Monmouth Junction, NJ 08852, USA